SHJ002

Sunhawk Vision Biotech, Inc. · Phase 2 active Small molecule Quality 0/100

At a glance

Generic name	SHJ002
Sponsor	Sunhawk Vision Biotech, Inc.
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Study of SHJ002 Sterile Ophthalmic Solution for Myopia Control (PHASE2)
Phase II Study of SHJ002 Sterile Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease (PHASE2)
Efficacy and Safety of SHJ002 Ophthalmic Solution in the Treatment of Corneal Erosion in Sjogren's Patients (PHASE2)
Phase 1 Study of SHJ002 Sterile Ophthalmic Solution in Pediatric Subjects (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

SHJ002 CI brief — competitive landscape report
SHJ002 updates RSS · CI watch RSS
Sunhawk Vision Biotech, Inc. portfolio CI